Literature DB >> 25706929

Diagnosis of 9q22.3 microdeletion syndrome in utero following identification of craniosynostosis, overgrowth, and skeletal anomalies.

Sara Chadwick Reichert1, Kristin Zelley, Kim E Nichols, Moriah Eberhard, Elaine H Zackai, Juan Martinez-Poyer.   

Abstract

9q22.3 microdeletion syndrome is a well-described contiguous deletion syndrome with features of Gorlin syndrome and other manifestations. Commonly reported findings in addition to those of Gorlin syndrome include metopic craniosynostosis, hydrocephalus, intellectual disability, and minor facial anomalies. The critical region for this condition was found to include the PTCH1 and FANCC genes; however, other genes are often deleted in affected individuals but their role in the observed phenotype is not understood. Fewer than 50 individuals with 9q22.3 microdeletion have been reported, all diagnosed postnatally on the basis of the phenotype. A confirmed prenatal diagnosis and accompanying fetal imaging has not been reported to date. We describe a patient with prenatally diagnosed 9q22.3 microdeletion syndrome following the ultrasonographic identification of trigonocephaly, macrosomia, organomegaly, ventriculomegaly, and anomalous vertebrae.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  9q22.3 microdeletion syndrome; Gorlin syndrome; craniosynostosis; macrosomia; prenatal diagnosis; prenatal microarray

Mesh:

Year:  2015        PMID: 25706929     DOI: 10.1002/ajmg.a.37013

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

1.  Unexpected phenotype in a frameshift mutation of PTCH1.

Authors:  Benedetta Beltrami; Elisabetta Prada; Gianluca Tolva; Giulietta Scuvera; Rosamaria Silipigni; Daniela Graziani; Gaetano Bulfamante; Cristina Gervasini; Paola Marchisio; Donatella Milani
Journal:  Mol Genet Genomic Med       Date:  2019-10-02       Impact factor: 2.183

2.  Microdeletion of 9q22.3: A patient with minimal deletion size associated with a severe phenotype.

Authors:  Adam D Ewing; Seth W Cheetham; James J McGill; Michael Sharkey; Rick Walker; Jennifer A West; Malcolm J West; Kim M Summers
Journal:  Am J Med Genet A       Date:  2021-05-07       Impact factor: 2.802

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.